204 related articles for article (PubMed ID: 21554259)
1. The clinical management of tumour lysis syndrome in haematological malignancies.
Will A; Tholouli E
Br J Haematol; 2011 Jul; 154(1):3-13. PubMed ID: 21554259
[TBL] [Abstract][Full Text] [Related]
2. Tumour lysis syndrome: new therapeutic strategies and classification.
Cairo MS; Bishop M
Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
[TBL] [Abstract][Full Text] [Related]
3. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
Darmon M; Vincent F; Camous L; Canet E; Bonmati C; Braun T; Caillot D; Cornillon J; Dimicoli S; Etienne A; Galicier L; Garnier A; Girault S; Hunault-Berger M; Marolleau JP; Moreau P; Raffoux E; Recher C; Thiebaud A; Thieblemont C; Azoulay E;
Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
[TBL] [Abstract][Full Text] [Related]
4. Tumor lysis syndrome.
Jeha S
Semin Hematol; 2001 Oct; 38(4 Suppl 10):4-8. PubMed ID: 11694945
[TBL] [Abstract][Full Text] [Related]
5. Tumour lysis syndrome.
Calvo Villas JM
Med Clin (Barc); 2019 May; 152(10):397-404. PubMed ID: 30612747
[TBL] [Abstract][Full Text] [Related]
6. Advances in the management of malignancy-associated hyperuricaemia.
Mahmoud HH; Leverger G; Patte C; Harvey E; Lascombes F
Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):18-20. PubMed ID: 9647616
[TBL] [Abstract][Full Text] [Related]
7. Tumor lysis syndrome: a systematic review of case series and case reports.
Firwana BM; Hasan R; Hasan N; Alahdab F; Alnahhas I; Hasan S; Varon J
Postgrad Med; 2012 Mar; 124(2):92-101. PubMed ID: 22437219
[TBL] [Abstract][Full Text] [Related]
8. Oncological emergencies: tumor lysis syndrome.
Sobota J; Püsküllüoglu M; Zygulska AL
Przegl Lek; 2014; 71(4):210-4. PubMed ID: 25141580
[TBL] [Abstract][Full Text] [Related]
9. Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome.
Ito S; Fujiwara SI; Yoshizawa T; Hayatsu K; Sekiguchi K; Murahashi R; Nakashima H; Matsuoka S; Ikeda T; Toda Y; Kawaguchi S; Nagayama T; Umino K; Minakata D; Nakano H; Morita K; Yamasaki R; Ashizawa M; Yamamoto C; Hatano K; Sato K; Ohmine K; Kanda Y
Intern Med; 2022 Nov; 61(21):3271-3275. PubMed ID: 35370238
[TBL] [Abstract][Full Text] [Related]
10. Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients.
Annemans L; Moeremans K; Lamotte M; Garcia Conde J; van den Berg H; Myint H; Pieters R; Uyttebroeck A
Support Care Cancer; 2003 Apr; 11(4):249-57. PubMed ID: 12673464
[TBL] [Abstract][Full Text] [Related]
11. Tumour lysis syndrome: a rare side effect of imatinib therapy for GIST.
Ondecker J; Kordic G; Jordan K
BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567109
[TBL] [Abstract][Full Text] [Related]
12. Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study.
Takai M; Yamauchi T; Ookura M; Matsuda Y; Tai K; Kishi S; Yoshida A; Iwasaki H; Nakamura T; Ueda T
Anticancer Res; 2014 Dec; 34(12):7287-96. PubMed ID: 25503162
[TBL] [Abstract][Full Text] [Related]
13. Management of hyperuricemia with rasburicase review.
de Bont JM; Pieters R
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1431-40. PubMed ID: 15571272
[TBL] [Abstract][Full Text] [Related]
14. Tumor Lysis Syndrome.
Barbar T; Jaffer Sathick I
Adv Chronic Kidney Dis; 2021 Sep; 28(5):438-446.e1. PubMed ID: 35190110
[TBL] [Abstract][Full Text] [Related]
15. Tumor lysis syndrome: risk factors, diagnosis, and management.
Burns RA; Topoz I; Reynolds SL
Pediatr Emerg Care; 2014 Aug; 30(8):571-6; quiz 577-9. PubMed ID: 25098804
[TBL] [Abstract][Full Text] [Related]
16. [Secondary hyperuricemia in hematologic disease].
Inai K; Tsutani H
Nihon Rinsho; 2003 Jan; 61 Suppl 1():299-303. PubMed ID: 12629735
[No Abstract] [Full Text] [Related]
17. Tumour lysis syndrome in haematological malignancies.
van der Hoven B; Thunnissen PL; Sizoo W
Neth J Med; 1992 Feb; 40(1-2):31-5. PubMed ID: 1579184
[TBL] [Abstract][Full Text] [Related]
18. Clarifying the role of rasburicase in tumor lysis syndrome.
Sood AR; Burry LD; Cheng DK
Pharmacotherapy; 2007 Jan; 27(1):111-21. PubMed ID: 17192165
[TBL] [Abstract][Full Text] [Related]
19. Management of pediatric tumor lysis syndrome.
Tazi I; Nafl H; Elhoudzi J; Mahmal L; Harif M
Arab J Nephrol Transplant; 2011 Sep; 4(3):147-54. PubMed ID: 22026339
[TBL] [Abstract][Full Text] [Related]
20. Tumour lysis syndrome in solid tumours.
Gemici C
Clin Oncol (R Coll Radiol); 2006 Dec; 18(10):773-80. PubMed ID: 17168213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
